Literature DB >> 25746479

Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease.

Haiyang Zhao1, Cuiqing Zhao2, Yuanyuan Dong1, Min Zhang3, Yuhua Wang3, Fengyuan Li4, Xiaokun Li5, Craig McClain6, Shulin Yang7, Wenke Feng8.   

Abstract

Alcoholic liver disease (ALD) has a high morbidity and mortality. Chronic alcohol consumption causes disruption of intestinal microflora homeostasis, intestinal tight junction barrier dysfunction, increased endotoxemia, and eventually liver steatosis/steatohepatitis. Probiotic Lactobacillus rhamnosus GG (LGG) and the bacteria-free LGG culture supernatant (LGGs) have been shown to promote intestinal epithelial integrity and protect intestinal barrier function in ALD. However, little is known about how LGGs mechanistically works to increase intestinal tight junction proteins. Here we show that chronic ethanol exposure increased intestinal miR122a expression, which decreased occludin expression leading to increased intestinal permeability. Moreover, LGGs supplementation decreased ethanol-elevated miR122a level and attenuated ethanol-induced liver injury in mice. Similar to the effect of ethanol exposure, overexpression of miR122a in Caco-2 monolayers markedly decreased occludin protein levels. In contrast, inhibition of miR122a increased occludin expression. We conclude that LGGs supplementation functions in intestinal integrity by inhibition of miR122a, leading to occludin restoration in mice exposed to chronic ethanol.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Alcohol; Intestine; Lactobacillus rhamnosus GG; Occludin; miR122a

Mesh:

Substances:

Year:  2015        PMID: 25746479     DOI: 10.1016/j.toxlet.2015.03.002

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  31 in total

1.  Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice.

Authors:  Qi Liu; Yunhuan Liu; Fengyuan Li; Zelin Gu; Min Liu; Tuo Shao; Lihua Zhang; Guangyao Zhou; Chengwei Pan; Liqing He; Jun Cai; Xiang Zhang; Shirish Barve; Craig J McClain; Yiping Chen; Wenke Feng
Journal:  J Nutr Biochem       Date:  2019-10-24       Impact factor: 6.048

Review 2.  Prospecting prebiotics, innovative evaluation methods, and their health applications: a review.

Authors:  Ishu Khangwal; Pratyoosh Shukla
Journal:  3 Biotech       Date:  2019-04-25       Impact factor: 2.406

Review 3.  Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?

Authors:  Lu Jiang; Bernd Schnabl
Journal:  Physiology (Bethesda)       Date:  2020-07-01

4.  Occludin deficiency promotes ethanol-induced disruption of colonic epithelial junctions, gut barrier dysfunction and liver damage in mice.

Authors:  Hina Mir; Avtar S Meena; Kamaljit K Chaudhry; Pradeep K Shukla; Ruchika Gangwar; Bhargavi Manda; Mythili K Padala; Le Shen; Jerrold R Turner; Paula Dietrich; Ioannis Dragatsis; RadhaKrishna Rao
Journal:  Biochim Biophys Acta       Date:  2015-12-23

5.  Acrolein Disrupts Tight Junction Proteins and Causes Endoplasmic Reticulum Stress-Mediated Epithelial Cell Death Leading to Intestinal Barrier Dysfunction and Permeability.

Authors:  Wei-Yang Chen; Min Wang; Jingwen Zhang; Shirish S Barve; Craig J McClain; Swati Joshi-Barve
Journal:  Am J Pathol       Date:  2017-09-19       Impact factor: 4.307

Review 6.  Targeting inflammation for the treatment of alcoholic liver disease.

Authors:  Ming-Jiang Xu; Zhou Zhou; Richard Parker; Bin Gao
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

7.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

Review 8.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

Review 9.  Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.

Authors:  Sena Bluemel; Brandon Williams; Rob Knight; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-29       Impact factor: 4.052

10.  Exosome-Like Nanoparticles From Lactobacillus rhamnosusGG Protect Against Alcohol-Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice.

Authors:  Zelin Gu; Fengyuan Li; Yunhuan Liu; Mengwei Jiang; Lihua Zhang; Liqing He; Daniel W Wilkey; Michael Merchant; Xiang Zhang; Zhong-Bin Deng; Shao-Yu Chen; Shirish Barve; Craig J McClain; Wenke Feng
Journal:  Hepatol Commun       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.